Please provide your email address to receive an email when new articles are posted on . Qdata Geographic Atrophy will improve understanding of practice patterns, decision-making and outcomes. The ...

Editor’s note: This is an automatically generated transcript, which has been slightly edited for clarity. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription.

IZERVAY (avacincaptad pegol intravitreal solution) is a prescription eye injection, used to treat geographic atrophy (GA), the advanced form of dry age-related macular degeneration (AMD). Eye ...

Randomized trials of two FDA-approved intravitreal complement inhibitor injections showed that they slowed the progression of geographic atrophy, but failed to demonstrate functional benefits at 24 ...

Geographic atrophy is a leading cause of blindness. The new approval will help to fill an unmet need for patients. The first ever treatment for geographic atrophy (GA) was approved by the FDA.

Geographic atrophy (GA) is a chronic, progressive degeneration of the macula that can occur in some people with dry macular degeneration. GA is a late, or advanced, stage of the disease. The people ...

A research team led by Professor Lee Hyun-ji (co-first authors Kim Sang-hoon, Kim Ji-eun, Joo Sung-jin, PhD student at Korea University Medical School, and co-corresponding author Lee Hyun-ji) ...

Spinal muscular atrophy (SMA) is a neuromuscular disorder that has no cure. People with a family history of SMA may consider screening to learn whether they carry the gene that causes the condition.

Peer-reviewed study from the bioMUSE Natural History Study shows advanced MRI method detects disease-specific iron accumulation that supports ...

Intravitreal complement inhibitor injections (IVCIs) for geographic atrophy appeared to be acceptable to most patients if they assumed the treatment had functional vision benefits, a cross-sectional ...